| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Global Head Of R&D | President, R&D | Director
2 companies
Cagnoni Pablo J is a President, Global Head Of R&D at INCY, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 11 sales. Those positions are worth an estimated $11.7M at current prices.
Cagnoni Pablo J's largest disclosed position is in INCY as President, Global Head Of R&D, worth about $11.7M. The recent filings there lean toward selling, a net 71,350 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | INCY Incyte Corporation | President, Global Head Of R&D | Sale+OE | 23,218 | $120.49 | $2,797,629.15 | -11.2% | |
| Aug 19, 2026 | INCY Incyte Corporation | President, Global Head Of R&D | Sell | 10,801 | $125.56 | $1,356,173.56 | -5.6% | |
| Aug 12, 2026 | INCY Incyte Corporation | President, Global Head Of R&D | Sell | 10,803 | $120.04 | $1,296,792.12 | -5.3% | |
| Aug 5, 2026 | INCY Incyte Corporation | President, Global Head Of R&D | Sell | 10,640 | $122.69 | $1,305,421.60 | -4.9% | |
| Jul 31, 2026 | INCY Incyte Corporation | President, Global Head Of R&D | Sell | 15,888 | $119.70 | $1,901,793.60 | -6.9% | |
| Nov 19, 2019 | CRSP Crispr Therapeutics AG | Director | Sale+OE | 7,500 | $62.00 | $465,000.00 | -100% | |
| Nov 12, 2019 | CRSP Crispr Therapeutics AG | Director | Sale+OE | 7,500 | $55.00 | $412,500.00 | -100% | |
| Oct 30, 2019 | CRSP Crispr Therapeutics AG | Director | Sale+OE | 7,500 | $52.00 | $390,000.00 | -100% | |
| Jul 5, 2018 | CRSP Crispr Therapeutics AG | Director | Sale+OE | 7,500 | $62.00 | $465,000.00 | -100% |